Sarepta Therapeutics Inc (SRPT)

135.36 +0.25  +0.19% NASDAQ Nov 25, 14:44 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/26/2021 Earnings Sarepta Therapeutics Inc Fourth Quarter Earnings for 2020 Release
02/26/2021 Misc Sarepta Therapeutics Inc Fourth Quarter Earnings Conference Call for 2020
11/05/2020 Earnings Sarepta Therapeutics Inc Third Quarter Earnings Result for 2020
11/05/2020 16:30 EST Misc Sarepta Therapeutics Inc Third Quarter Earnings Conference Call for 2020
08/05/2020 16:30 EDT Misc Sarepta Therapeutics Inc Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Sarepta Therapeutics Inc Second Quarter Earnings Result for 2020
06/04/2020 09:00 EDT Misc Sarepta Therapeutics Inc Annual General Meeting for 2019
05/06/2020 16:30 EDT Misc Sarepta Therapeutics Inc First Quarter Earnings Conference Call for 2020
05/06/2020 Earnings Sarepta Therapeutics Inc First Quarter Earnings Result for 2020
02/26/2020 16:30 EST Misc Sarepta Therapeutics Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.sarepta.com
  • Investor Relations URL: http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 26, 2021
  • Last Earnings Release: Nov. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Top Fund Holders

Symbol Name Weighting
ETCHX Eventide Healthcare & Life Sciences C 5.70%
FBT First Trust NYSE Arca Biotech ETF 3.17%
BBH VanEck Vectors Biotech ETF 2.81%
DFRIX Delaware Smid Cap Growth R 1.99%
HQL Tekla Life Sciences Investors 1.69%
WSTBX Ivy Science And Technology B 1.43%
FBIOX Fidelity® Select Biotechnology 1.38%
HQH Tekla Healthcare Investors 1.34%
IBB iShares Nasdaq Biotechnology ETF 1.11%
JGMCX Janus Henderson Triton C 1.10%
VISGX Vanguard Small Cap Growth Index Inv 0.56%
VBK Vanguard Small-Cap Growth ETF 0.56%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.